Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Nafoxidine

Copy Product Info
🥰Excellent
Catalog No. T21387LCas No. 1845-11-0

Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.

Nafoxidine

Nafoxidine

Copy Product Info
🥰Excellent
Purity: 99.93%
Catalog No. T21387LCas No. 1845-11-0
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$36In StockIn Stock
10 mg$53In StockIn Stock
25 mg$98In StockIn Stock
50 mg$155In StockIn Stock
100 mg$248In StockIn Stock
200 mg$368In StockIn Stock
1 mL x 10 mM (in DMSO)$45In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.93%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Nafoxidine AI Summary
Nafoxidine exhibits a multifaceted bioactivity profile. It shows uterotrophic activity in rats relative to estradiol with a relative activity of 5.5 and demonstrates a relative binding affinity (RBA) for uterine cytosolic estrogen receptors of immature rats at 9.29%. Additionally, it possesses antiimplantation activity in sperm-positive female rats at a minimum effective dose of 0.1 mg kg^-1. The compound also exhibits antiestrogenic effects, inhibiting estrus in ovariectomized rats treated with 17-beta-estradiol with an inhibition rate of 44.0%, and prevents estradiol binding to estrogen receptors with an IC50 of 40.9 nM. In terms of binding affinity, Nafoxidine shows an RBA of 183.0 for chicken liver, 90.0 for rat liver, and 124.0 for guinea pig uterus, suggesting strong antiestrogenic potential. It also binds to human EMP and sigma receptor type 1 with Ki values of 0.9 nM and 30.0 nM, respectively, and exhibits affinity for ERG2 in Saccharomyces cerevisiae with a Ki of 232.0 nM. Against the recombinant rat androgen receptor, it has an IC50 of 12882.5 nM. Further, Nafoxidine demonstrates antiviral activity in different contexts. Against SARS-CoV-2, it exhibits an IC50 > 100000.0 nM, indicating weak potency, and shows a CC50 of 3850.0 nM in VERO-E6 cells. It also inhibits pseudotyped Marburgvirus and Ebola virus strains in human A549 cells with varied IC50 values, highlighting its selective antiviral potential. This compound's complex bioactivity profile suggests potential applications in estrogen receptor modulation, antiviral therapies, and antiestrogenic treatments..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Nafoxidine is an estrogen antagonist that has been used in the treatment of breast cancer.
Chemical Properties
Molecular Weight425.56
FormulaC29H31NO2
Cas No.1845-11-0
SmilesO(C)C=1C=C2C(C(=C(CC2)C3=CC=CC=C3)C4=CC=C(OCCN5CCCC5)C=C4)=CC1
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 65 mg/mL (152.74 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.7 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3498 mL11.7492 mL23.4984 mL117.4922 mL
5 mM0.4700 mL2.3498 mL4.6997 mL23.4984 mL
10 mM0.2350 mL1.1749 mL2.3498 mL11.7492 mL
20 mM0.1175 mL0.5875 mL1.1749 mL5.8746 mL
50 mM0.0470 mL0.2350 mL0.4700 mL2.3498 mL
100 mM0.0235 mL0.1175 mL0.2350 mL1.1749 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Nafoxidine | purchase Nafoxidine | Nafoxidine cost | order Nafoxidine | Nafoxidine chemical structure | Nafoxidine formula | Nafoxidine molecular weight